Athenahealth (ATHN) October IV elevated at 163 into Q3

Go back to Athenahealth (ATHN) October IV elevated at 163 into Q3

athenahealth (ATHN) PT Lowered to $155 at Baird Following Conference Call

October 23, 2017 8:52 AM EDT

Baird lowered its price target on athenahealth (NASDAQ: ATHN) to $155.00 (from $170.00) while maintaining a Outperform rating following conference call. Commentary from the call was mostly positive. Management emphasized non-GAAP EBIT margins for 2018 would be at least 15% for the full year, which implies run-rate... More